Degeneration Saline group presented with significant decreased final weight in relation to other groups. حسب Flavia Gomes Velasque Gama (21175112)

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. حسب Nadia Gul (249538)

الموضوعات:

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. حسب Jie Zhao (49409)

الموضوعات:

Impact on different areas of health. حسب Margherita Molaro (17803989)

Thermoneutrality decreased sepsis survival. حسب Goldia Chan (21453340)

Smoking Behaviors of the participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Drinking Behaviors of the male participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Drinking Behaviors of the participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Sleep and Mental health of the participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

General characteristics of the participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Difference in drinking, smoking, and suicidal ideation by year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Drinking Behaviors of the female participants categorized by the respective year. حسب Jae Yeon Jeong (11979030)

الموضوعات:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. حسب Jie Zhao (49409)

الموضوعات:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. حسب Jie Zhao (49409)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات: